“…As reported in the available scientific literature, 7‐oxo‐DHEA ( 1 ) metabolism in humans is mainly concerned with the reduction of C‐17 ketone by 17β‐hydroxysteroid dehydrogenase (17β‐HSD) generating 3β,17β‐dihydroxy‐androst‐5‐en‐7‐one ( 2 ) or/and reduction of the ketone at C‐7 position by 11β‐HSD1 leading to the formation of epimeric 7β‐ (mainly) and 7α‐ alcohols (7α‐ and 7β‐hydroxy‐DHEA ( 3 )), and their reduction to 3β,7α,17β‐ and 3β,7β,17β‐triols (3β,7α,17β‐trihydroxy‐androst‐5‐ene ( 4 ) and 3β,7β,17β‐trihydroxy‐androst‐5‐ene ( 5 )) (Nashev et al ., 2007). These metabolites are multifunctional compounds implicated in a broad range of biological processes, mainly attributed to immune system modulation, anti‐inflammatory, antiglucocorticoid and neuroprotective actions (El Kihel, 2012; Stárka, 2017; Stárka et al ., 2018). Changes in the ratio of 7α/7β‐hydroxy‐DHEA and both isomeric triols were detected in patients with various disorders including vascular and Alzheimer dementia (Stárka, 2017).…”